These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 26758431

  • 1. miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.
    Zhou S, Wang B, Hu J, Zhou Y, Jiang M, Wu M, Qin L, Yang X.
    Tumour Biol; 2016 Jul; 37(7):9001-7. PubMed ID: 26758431
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long Noncoding MT1JP Enhanced the Inhibitory Effects of miR-646 on FGF2 in Osteosarcoma.
    Yang L, Liu G, Xiao S, Wang L, Liu X, Tan Q, Li Z.
    Cancer Biother Radiopharm; 2020 Jun; 35(5):371-376. PubMed ID: 32196384
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic and prognostic implications of serum miR-101 in osteosarcoma.
    Yao ZS, Li C, Liang D, Jiang XB, Tang JJ, Ye LQ, Yuan K, Ren H, Yang ZD, Jin DX, Zhang SC, Ding JY, Tang YC, Xu JX, Chen K, Xie WX, Guo DQ, Cui JC.
    Cancer Biomark; 2018 Jun; 22(1):127-133. PubMed ID: 29630525
    [Abstract] [Full Text] [Related]

  • 7. MiR-221 increases osteosarcoma cell proliferation, invasion and migration partly through the downregulation of PTEN.
    Zhu J, Liu F, Wu Q, Liu X.
    Int J Mol Med; 2015 Nov; 36(5):1377-83. PubMed ID: 26397386
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MicroRNA-99b predicts clinical outcome of osteosarcoma and suppresses tumor cell proliferation, migration and invasion.
    Shi X, Guan X.
    Diagn Pathol; 2019 Oct 24; 14(1):117. PubMed ID: 31651329
    [Abstract] [Full Text] [Related]

  • 15. MiR-125b Functions as a Tumor Suppressor and Enhances Chemosensitivity to Cisplatin in Osteosarcoma.
    Wang F, Yu D, Liu Z, Wang R, Xu Y, Cui H, Zhao T.
    Technol Cancer Res Treat; 2016 Dec 24; 15(6):NP105-NP112. PubMed ID: 26744308
    [Abstract] [Full Text] [Related]

  • 16. miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2).
    Sun XH, Geng XL, Zhang J, Zhang C.
    Tumour Biol; 2015 Mar 24; 36(3):2127-34. PubMed ID: 25403884
    [Abstract] [Full Text] [Related]

  • 17. Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.
    Zeng H, Zhang Z, Dai X, Chen Y, Ye J, Jin Z.
    Pathol Oncol Res; 2016 Apr 24; 22(2):253-60. PubMed ID: 26183062
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MicroRNA-33b Inhibits the Proliferation and Migration of Osteosarcoma Cells via Targeting Hypoxia-Inducible Factor-1α.
    Zhou Y, Yang C, Wang K, Liu X, Liu Q.
    Oncol Res; 2017 Mar 13; 25(3):397-405. PubMed ID: 27662380
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.